The metabolic cost of lowering blood pressure with hydrochlorothiazide

BACKGROUND: The landmark Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT) placed a new spotlight on thiazide diuretics as the first-line therapy for hypertension. This is concerning as thiazide-diuretics may contribute to comorbidities associated with the current...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Price, Angela L, Lingvay, Ildiko, Szczepaniak, Edward W, Wiebel, Jaime, Victor, Ronald G, Szczepaniak, Lidia S
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2013
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3711837/
https://ncbi.nlm.nih.gov/pubmed/23837919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1758-5996-5-35
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires